346 related articles for article (PubMed ID: 30871490)
1. Prognostic models for breast cancer: a systematic review.
Phung MT; Tin Tin S; Elwood JM
BMC Cancer; 2019 Mar; 19(1):230. PubMed ID: 30871490
[TBL] [Abstract][Full Text] [Related]
2. Development and validation of a new predictive model for breast cancer survival in New Zealand and comparison to the Nottingham prognostic index.
Elwood JM; Tawfiq E; TinTin S; Marshall RJ; Phung TM; Campbell I; Harvey V; Lawrenson R
BMC Cancer; 2018 Sep; 18(1):897. PubMed ID: 30223800
[TBL] [Abstract][Full Text] [Related]
3. Personalized Prognostic Prediction Models for Breast Cancer Recurrence and Survival Incorporating Multidimensional Data.
Wu X; Ye Y; Barcenas CH; Chow WH; Meng QH; Chavez-MacGregor M; Hildebrandt MA; Zhao H; Gu X; Deng Y; Wagar E; Esteva FJ; Tripathy D; Hortobagyi GN
J Natl Cancer Inst; 2017 Jul; 109(7):. PubMed ID: 28376179
[TBL] [Abstract][Full Text] [Related]
4. Comparison of Nottingham Prognostic Index and Adjuvant Online prognostic tools in young women with breast cancer: review of a single-institution experience.
Hearne BJ; Teare MD; Butt M; Donaldson L
BMJ Open; 2015 Jan; 5(1):e005576. PubMed ID: 25628047
[TBL] [Abstract][Full Text] [Related]
5. Metastasis-free interval in breast cancer patients: Thirty-year trends and time dependency of prognostic factors. A retrospective analysis based on a single institution experience.
Houzé de l'Aulnoit A; Rogoz B; Pinçon C; Houzé de l'Aulnoit D
Breast; 2018 Feb; 37():80-88. PubMed ID: 29102782
[TBL] [Abstract][Full Text] [Related]
6. Predictors of time to death after distant recurrence in breast cancer patients.
Sopik V; Sun P; Narod SA
Breast Cancer Res Treat; 2019 Jan; 173(2):465-474. PubMed ID: 30328050
[TBL] [Abstract][Full Text] [Related]
7. Determination of GP88 (progranulin) expression in breast tumor biopsies improves the risk predictive value of the Nottingham Prognostic Index.
Serrero G; Hawkins DM; Bejarano PA; Ioffe O; Tkaczuk KR; Elliott RE; Head JF; Phillips J; Godwin AK; Weaver J; Hicks D; Yue B
Diagn Pathol; 2016 Aug; 11(1):71. PubMed ID: 27501955
[TBL] [Abstract][Full Text] [Related]
8. Estimation and external validation of a new prognostic model for predicting recurrence-free survival for early breast cancer patients in the UK.
Campbell HE; Gray AM; Harris AL; Briggs AH; Taylor MA
Br J Cancer; 2010 Sep; 103(6):776-86. PubMed ID: 20823886
[TBL] [Abstract][Full Text] [Related]
9. The Practicability of a Novel Prognostic Index (PI) Model and Comparison with Nottingham Prognostic Index (NPI) in Stage I-III Breast Cancer Patients Undergoing Surgical Treatment.
Wen J; Ye F; Li S; Huang X; Yang L; Xiao X; Xie X
PLoS One; 2015; 10(11):e0143537. PubMed ID: 26600129
[TBL] [Abstract][Full Text] [Related]
10. Are symptomatic guidelines for chemotherapy appropriate to ER-positive screen-detected breast cancer (SDBC)?
Bundred NJ; Prasad R; Morris J; Knox WF; Byrne G; Cheung S; Wilson M; Lawrence G
Breast Cancer Res Treat; 2013 Apr; 138(2):359-68. PubMed ID: 21744241
[TBL] [Abstract][Full Text] [Related]
11. DC-SCRIPT: nuclear receptor modulation and prognostic significance in primary breast cancer.
Ansems M; Hontelez S; Looman MW; Karthaus N; Bult P; Bonenkamp JJ; Jansen JH; Sweep FC; Span PN; Adema GJ
J Natl Cancer Inst; 2010 Jan; 102(1):54-68. PubMed ID: 20008677
[TBL] [Abstract][Full Text] [Related]
12. Prognostic Tools for Older Women with Breast Cancer: A Systematic Review.
Record SM; Chanenchuk T; Parrish KM; Kaplan SJ; Kimmick G; Plichta JK
Medicina (Kaunas); 2023 Aug; 59(9):. PubMed ID: 37763695
[No Abstract] [Full Text] [Related]
13. Prognostic factors in breast cancer: the value of the Nottingham Prognostic Index for patients treated in a single institution.
Okugawa H; Yamamoto D; Uemura Y; Sakaida N; Yamada M; Tanaka K; Kamiyama Y
Surg Today; 2005; 35(11):907-11. PubMed ID: 16249842
[TBL] [Abstract][Full Text] [Related]
14. A novel morphologic-molecular recurrence predictive model refines traditional prognostic tools for invasive breast carcinoma.
Ni YB; Tsang JY; Chan SK; Tse GM
Ann Surg Oncol; 2014 Sep; 21(9):2928-33. PubMed ID: 24743910
[TBL] [Abstract][Full Text] [Related]
15. Factors influencing breast cancer outcomes in Australia: A systematic review.
Ho-Huynh A; Tran A; Bray G; Abbot S; Elston T; Gunnarsson R; de Costa A
Eur J Cancer Care (Engl); 2019 Jul; 28(4):e13038. PubMed ID: 30919536
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of the prognostic stage in the 8th edition of the American Joint Committee on Cancer in locally advanced breast cancer: An analysis based on SEER 18 database.
Wang M; Chen H; Wu K; Ding A; Zhang M; Zhang P
Breast; 2018 Feb; 37():56-63. PubMed ID: 29100045
[TBL] [Abstract][Full Text] [Related]
17. Prognostic contribution of mammographic breast density and HER2 overexpression to the Nottingham Prognostic Index in patients with invasive breast cancer.
Masarwah A; Auvinen P; Sudah M; Dabravolskaite V; Arponen O; Sutela A; Oikari S; Kosma VM; Vanninen R
BMC Cancer; 2016 Nov; 16(1):833. PubMed ID: 27806715
[TBL] [Abstract][Full Text] [Related]
18. Different patterns in the prognostic value of age for breast cancer-specific mortality depending on hormone receptor status: a SEER population-based analysis.
Liu YR; Jiang YZ; Yu KD; Shao ZM
Ann Surg Oncol; 2015 Apr; 22(4):1102-10. PubMed ID: 25249260
[TBL] [Abstract][Full Text] [Related]
19. Development of a prediction model for breast cancer based on the national cancer registry in Taiwan.
Huang CC; Chan SY; Lee WC; Chiang CJ; Lu TP; Cheng SH
Breast Cancer Res; 2019 Aug; 21(1):92. PubMed ID: 31409418
[TBL] [Abstract][Full Text] [Related]
20. PPFIA1 is upregulated in liver metastasis of breast cancer and is a potential poor prognostic indicator of metastatic relapse.
Yang J; Wu NN; Huang DJ; Luo YC; Huang JZ; He HY; Lu HL; Song WL
Tumour Biol; 2017 Jul; 39(7):1010428317713492. PubMed ID: 28720060
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
